| Dr Iryna Vitaliyivna Polyakova, DO | |
|
1201 S Main St, Crown Point, IN 46307-8481 | |
| (219) 738-2100 | |
| (219) 933-2288 |
| Full Name | Dr Iryna Vitaliyivna Polyakova |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 9 Years |
| Location | 1201 S Main St, Crown Point, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447633326 | NPI | - | NPPES |
| JK466 | Other | FL | FL MEDICARE |
| P02211193 | Other | FL | FL RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS15044 (Florida) | Secondary |
| 207Q00000X | Family Medicine | 02006069A (Indiana) | Secondary |
| 208M00000X | Hospitalist | 02006069A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Elkhart General Hospital | Elkhart, IN | Hospital |
| Community Hospital Of Bremen Inc | Bremen, IN | Hospital |
| Saint Joseph Regional Medical Center - Plymouth | Plymouth, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Apogee Medical Group Indiana Pc | 8729155742 | 60 |
| Community Hospital Of Bremen Inc | 6002897451 | 4 |
| Saint Joseph Regional Medical Center- Plymouth Campus Inc | 9537071337 | 19 |
News Archive
Patients with diabetic macular oedema have smaller choroidal thickness measurements in affected and unaffected eyes compared with healthy individuals, spectral-domain optical coherence tomography imaging results reveal.
Researchers in the Division of Cancer Prevention, Department of Medicine, at Stony Brook University have discovered that a novel derivative of sulindac, a non-steroidal anti-inflammatory drug (NSAID) known to prevent colon cancer, is more effective and safer than sulindac in preventing colon cancer in animals. The study results are reported in the October issue of the journal Gastroenterology.
Researchers have identified a new variant form of Guillain-Barré syndrome that is characterised by prominent acute bulbar palsy without neck or limb weakness.
A synthetic estrogen — diethylstilbestrol (DES), prescribed to women in the 1940s, 1950s, and 1960s to prevent miscarriages, had serious, untoward effects in daughters of these women, including the development of a rare type of cancer of the uterus.
Cell Therapeutics, Inc. announced today its support of the Pharmaceutical Research Manufacturers of America's (PhRMA) "Code on Interactions with Healthcare Professionals, revised July 2008" (PhRMA Code). Adherence to the Code is voluntary for commercial biotechnology and pharmaceutical companies.
› Verified 7 days ago
| Entity Name | Saint Joseph Regional Medical Center- Plymouth Campus Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538585187 PECOS PAC ID: 9537071337 Enrollment ID: O20031223000588 |
News Archive
Patients with diabetic macular oedema have smaller choroidal thickness measurements in affected and unaffected eyes compared with healthy individuals, spectral-domain optical coherence tomography imaging results reveal.
Researchers in the Division of Cancer Prevention, Department of Medicine, at Stony Brook University have discovered that a novel derivative of sulindac, a non-steroidal anti-inflammatory drug (NSAID) known to prevent colon cancer, is more effective and safer than sulindac in preventing colon cancer in animals. The study results are reported in the October issue of the journal Gastroenterology.
Researchers have identified a new variant form of Guillain-Barré syndrome that is characterised by prominent acute bulbar palsy without neck or limb weakness.
A synthetic estrogen — diethylstilbestrol (DES), prescribed to women in the 1940s, 1950s, and 1960s to prevent miscarriages, had serious, untoward effects in daughters of these women, including the development of a rare type of cancer of the uterus.
Cell Therapeutics, Inc. announced today its support of the Pharmaceutical Research Manufacturers of America's (PhRMA) "Code on Interactions with Healthcare Professionals, revised July 2008" (PhRMA Code). Adherence to the Code is voluntary for commercial biotechnology and pharmaceutical companies.
› Verified 7 days ago
| Entity Name | Saint Joseph Regional Medical Center-south Bend Campus Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841245594 PECOS PAC ID: 3476451790 Enrollment ID: O20031223000724 |
News Archive
Patients with diabetic macular oedema have smaller choroidal thickness measurements in affected and unaffected eyes compared with healthy individuals, spectral-domain optical coherence tomography imaging results reveal.
Researchers in the Division of Cancer Prevention, Department of Medicine, at Stony Brook University have discovered that a novel derivative of sulindac, a non-steroidal anti-inflammatory drug (NSAID) known to prevent colon cancer, is more effective and safer than sulindac in preventing colon cancer in animals. The study results are reported in the October issue of the journal Gastroenterology.
Researchers have identified a new variant form of Guillain-Barré syndrome that is characterised by prominent acute bulbar palsy without neck or limb weakness.
A synthetic estrogen — diethylstilbestrol (DES), prescribed to women in the 1940s, 1950s, and 1960s to prevent miscarriages, had serious, untoward effects in daughters of these women, including the development of a rare type of cancer of the uterus.
Cell Therapeutics, Inc. announced today its support of the Pharmaceutical Research Manufacturers of America's (PhRMA) "Code on Interactions with Healthcare Professionals, revised July 2008" (PhRMA Code). Adherence to the Code is voluntary for commercial biotechnology and pharmaceutical companies.
› Verified 7 days ago
| Entity Name | Community Hospital Of Bremen Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902017080 PECOS PAC ID: 6002897451 Enrollment ID: O20040601000388 |
News Archive
Patients with diabetic macular oedema have smaller choroidal thickness measurements in affected and unaffected eyes compared with healthy individuals, spectral-domain optical coherence tomography imaging results reveal.
Researchers in the Division of Cancer Prevention, Department of Medicine, at Stony Brook University have discovered that a novel derivative of sulindac, a non-steroidal anti-inflammatory drug (NSAID) known to prevent colon cancer, is more effective and safer than sulindac in preventing colon cancer in animals. The study results are reported in the October issue of the journal Gastroenterology.
Researchers have identified a new variant form of Guillain-Barré syndrome that is characterised by prominent acute bulbar palsy without neck or limb weakness.
A synthetic estrogen — diethylstilbestrol (DES), prescribed to women in the 1940s, 1950s, and 1960s to prevent miscarriages, had serious, untoward effects in daughters of these women, including the development of a rare type of cancer of the uterus.
Cell Therapeutics, Inc. announced today its support of the Pharmaceutical Research Manufacturers of America's (PhRMA) "Code on Interactions with Healthcare Professionals, revised July 2008" (PhRMA Code). Adherence to the Code is voluntary for commercial biotechnology and pharmaceutical companies.
› Verified 7 days ago
| Entity Name | Apogee Medical Group Indiana Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093973885 PECOS PAC ID: 8729155742 Enrollment ID: O20080917000320 |
News Archive
Patients with diabetic macular oedema have smaller choroidal thickness measurements in affected and unaffected eyes compared with healthy individuals, spectral-domain optical coherence tomography imaging results reveal.
Researchers in the Division of Cancer Prevention, Department of Medicine, at Stony Brook University have discovered that a novel derivative of sulindac, a non-steroidal anti-inflammatory drug (NSAID) known to prevent colon cancer, is more effective and safer than sulindac in preventing colon cancer in animals. The study results are reported in the October issue of the journal Gastroenterology.
Researchers have identified a new variant form of Guillain-Barré syndrome that is characterised by prominent acute bulbar palsy without neck or limb weakness.
A synthetic estrogen — diethylstilbestrol (DES), prescribed to women in the 1940s, 1950s, and 1960s to prevent miscarriages, had serious, untoward effects in daughters of these women, including the development of a rare type of cancer of the uterus.
Cell Therapeutics, Inc. announced today its support of the Pharmaceutical Research Manufacturers of America's (PhRMA) "Code on Interactions with Healthcare Professionals, revised July 2008" (PhRMA Code). Adherence to the Code is voluntary for commercial biotechnology and pharmaceutical companies.
› Verified 7 days ago
| Entity Name | Hospitalist Physicians Of Indiana Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306576277 PECOS PAC ID: 1052795986 Enrollment ID: O20220826000967 |
News Archive
Patients with diabetic macular oedema have smaller choroidal thickness measurements in affected and unaffected eyes compared with healthy individuals, spectral-domain optical coherence tomography imaging results reveal.
Researchers in the Division of Cancer Prevention, Department of Medicine, at Stony Brook University have discovered that a novel derivative of sulindac, a non-steroidal anti-inflammatory drug (NSAID) known to prevent colon cancer, is more effective and safer than sulindac in preventing colon cancer in animals. The study results are reported in the October issue of the journal Gastroenterology.
Researchers have identified a new variant form of Guillain-Barré syndrome that is characterised by prominent acute bulbar palsy without neck or limb weakness.
A synthetic estrogen — diethylstilbestrol (DES), prescribed to women in the 1940s, 1950s, and 1960s to prevent miscarriages, had serious, untoward effects in daughters of these women, including the development of a rare type of cancer of the uterus.
Cell Therapeutics, Inc. announced today its support of the Pharmaceutical Research Manufacturers of America's (PhRMA) "Code on Interactions with Healthcare Professionals, revised July 2008" (PhRMA Code). Adherence to the Code is voluntary for commercial biotechnology and pharmaceutical companies.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Iryna Vitaliyivna Polyakova, DO Po Box 781076, Detroit, MI 48278-1076 Ph: (317) 528-4800 | Dr Iryna Vitaliyivna Polyakova, DO 1201 S Main St, Crown Point, IN 46307-8481 Ph: (219) 738-2100 |
News Archive
Patients with diabetic macular oedema have smaller choroidal thickness measurements in affected and unaffected eyes compared with healthy individuals, spectral-domain optical coherence tomography imaging results reveal.
Researchers in the Division of Cancer Prevention, Department of Medicine, at Stony Brook University have discovered that a novel derivative of sulindac, a non-steroidal anti-inflammatory drug (NSAID) known to prevent colon cancer, is more effective and safer than sulindac in preventing colon cancer in animals. The study results are reported in the October issue of the journal Gastroenterology.
Researchers have identified a new variant form of Guillain-Barré syndrome that is characterised by prominent acute bulbar palsy without neck or limb weakness.
A synthetic estrogen — diethylstilbestrol (DES), prescribed to women in the 1940s, 1950s, and 1960s to prevent miscarriages, had serious, untoward effects in daughters of these women, including the development of a rare type of cancer of the uterus.
Cell Therapeutics, Inc. announced today its support of the Pharmaceutical Research Manufacturers of America's (PhRMA) "Code on Interactions with Healthcare Professionals, revised July 2008" (PhRMA Code). Adherence to the Code is voluntary for commercial biotechnology and pharmaceutical companies.
› Verified 7 days ago
Nicole M Cataldi, D.O. Hospitalist Medicare: Medicare Enrolled Practice Location: 800 W Burrell Dr, Crown Point, IN 46307 Phone: 219-663-9913 Fax: 219-663-9923 | |
Dr. Yu Liu, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 12750 St Francis Dr, Crown Point, IN 46307 Phone: 219-757-6121 Fax: 219-681-6897 | |
Usman Syed Ather, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 12750 St Francis Dr, Crown Point, IN 46307 Phone: 219-757-6121 Fax: 219-681-6897 | |
Kenneth Polezoes, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 7310 W Lincoln Hwy, Crown Point, IN 46307 Phone: 219-322-4637 Fax: 219-322-5298 | |
Rayon Golding, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 12750 St Francis Dr, Crown Point, IN 46307 Phone: 219-757-6121 Fax: 219-681-6897 | |
Zhipeng Zhang, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 12750 St Francis Dr, Crown Point, IN 46307 Phone: 219-757-6121 Fax: 219-681-6897 | |
Jennifer Lynn Kelly, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1201 S Main St, Crown Point, IN 46307 Phone: 219-738-2100 Fax: 219-933-2288 |